Lowering insulin prices isn’t the (only) answer to helping patients with diabetes July 18, 2022 AutoBot BioPharma, biopharma nl, Legal, MedCity Influencers, obesity, Opinion, Type 2 Diabetes 0 It is time to shift the conversation, incentives, and policy solutions to help people improve their health and get off of medications—not just make them cheaper.